EBBINGHAUS

Trial name or title	EBBINGHAUS
Methods	Parallel randomised controlled trials
Participants	People 40 to 85 years of age Inclusion criteria Randomised into Study 20110118 (FOURIER) Exclusion criteria Current or known past diagnosis of dementia or mild cognitive impairment (MCI)
Interventions	Evolocumab compared with statin therapy in combination with placebo
Outcomes	Mean change from baseline over time in spatial working memory (SWM) index of executive function
Starting date	July 2014
Contact information
Notes	Amgen, substudy of FOURIER